Integral Health Asset Management LLC Invests $22.45 Million in CVS Health Co. (NYSE:CVS)

Integral Health Asset Management LLC purchased a new position in CVS Health Co. (NYSE:CVS - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 500,000 shares of the pharmacy operator's stock, valued at approximately $22,445,000. CVS Health comprises 1.9% of Integral Health Asset Management LLC's holdings, making the stock its 13th largest position.

Several other large investors also recently modified their holdings of CVS. Stonebridge Financial Group LLC bought a new position in CVS Health in the 4th quarter worth $28,000. Hopwood Financial Services Inc. purchased a new stake in CVS Health in the fourth quarter worth about $29,000. Financial Perspectives Inc raised its stake in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after buying an additional 466 shares during the period. Compass Planning Associates Inc purchased a new position in shares of CVS Health during the 4th quarter valued at about $37,000. Finally, MidAtlantic Capital Management Inc. grew its stake in shares of CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after acquiring an additional 437 shares during the period. Institutional investors own 80.66% of the company's stock.

Insider Transactions at CVS Health

In other news, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This trade represents a 320.65% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP James David Clark sold 7,513 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at $556,941.90. This trade represents a 47.23% decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.22% of the company's stock.

CVS Health Price Performance

Shares of CVS stock traded up $0.38 on Thursday, reaching $60.42. The company's stock had a trading volume of 11,209,003 shares, compared to its average volume of 11,467,736. The stock's fifty day simple moving average is $66.71 and its 200-day simple moving average is $59.15. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $72.51. The company has a market capitalization of $76.43 billion, a price-to-earnings ratio of 16.51, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The business had revenue of $94.59 billion during the quarter, compared to analysts' expectations of $93.07 billion. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business's revenue was up 7.0% on a year-over-year basis. During the same period last year, the company posted $1.31 EPS. Analysts forecast that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.40%. The ex-dividend date was Tuesday, April 22nd. CVS Health's payout ratio is 63.48%.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and lifted their price target for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Mizuho lifted their target price on shares of CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. Robert W. Baird increased their price target on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Argus set a $77.00 price objective on CVS Health in a research report on Tuesday, February 18th. Finally, StockNews.com upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $74.94.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.